Zone7 is an AI platform to optimize human performance by protecting health, potential, and durability of athletes & elite workforce.
Zone7 has raised $8.0M in total funding. The most recent round was Series A. The last funding was announced in July 2021.
Zone7's investors include Alumni Ventures, Analog Ventures, UpWest, Resolute Ventures, ValueStream Ventures.
Zone7 is headquartered in Palo Alto, United States.
Zone7 is an AI platform to optimize human performance by protecting health, potential, and durability of athletes & elite workforce.
Zone7 is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Zone7 — Funding & Investors." VCBacked, July 22, 2021, https://www.vcbacked.co/company/zone7. Accessed September 30, 2026.
VCBacked. (2021). Zone7 — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/zone7
{{cite web |title=Zone7 — Funding & Investors |url=https://www.vcbacked.co/company/zone7 |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated